Peptide API Market
Peptide API Market Size, Share & Trends Analysis Report
Peptide API Market Size, Share, Statistics & Trends Analysis By Product Type (Hormonal Peptides, Cyclic Peptides, Linear Peptides, Peptide Derivatives) By Therapeutic Area (Oncology, Diabetes, Cardiovascular, Central Nervous System (CNS), Infectious Diseases, Others) By Route of Administration (Injectables, Oral, Others) By Source (Natural Sources, Synthetic Sources) By Application (Research and Development, Commercial Production) Other Based On Region, And Segment Forecasts, 2025 – 2031
Published
Report ID : BMRC 6767
Number of pages : 300
Published Date : Apr 2025
Category : Healthcare
Delivery Timeline : 48 hrs
Key Players
- Novo Nordisk A/S (Denmark)
- Bachem Holding AG (Switzerland)
- AstraZeneca (UK)
- Merck KGaA (Germany)
- Amgen Inc. (U.S.)
- Lundbeck A/S (Denmark)
- PeptiDream Inc. (Japan)
- PolyPeptide Group (France)
- Thermo Fisher Scientific Inc. (U.S.)
- AmbioPharm, Inc. (U.S.)
- CordenPharma International GmbH (Germany)
- Lonza Group Ltd. (Switzerland)
- CSBio Company, Inc. (U.S.)
- ChemPartner Co., Ltd. (China)
- Reddy's Laboratories Ltd. (India)
- Teva Pharmaceutical Industries Ltd. (Israel)
- Ferring Pharmaceuticals (Switzerland)
- Pfizer Inc. (U.S.)
Market Segmentation
By Product Type
- Hormonal Peptides
- Cyclic Peptides
- Linear Peptides
- Peptide Derivatives
By Therapeutic Area
- Oncology
- Diabetes
- Cardiovascular
- Central Nervous System (CNS)
- Infectious Diseases
- Others
By Route of Administration
- Injectables
- Oral
- Others
By Source
- Natural Sources
- Synthetic Sources
By Application
- Research and Development
- Commercial Production
SUMMARY
Segments
Market Segmentation
By Product Type
- Hormonal Peptides
- Cyclic Peptides
- Linear Peptides
- Peptide Derivatives
By Therapeutic Area
- Oncology
- Diabetes
- Cardiovascular
- Central Nervous System (CNS)
- Infectious Diseases
- Others
By Route of Administration
- Injectables
- Oral
- Others
By Source
- Natural Sources
- Synthetic Sources
By Application
- Research and Development
- Commercial Production
Regions and Country
North America
- U.S.
- Canada
Europe
- Germany
- France
- U.K.
- Italy
- Spain
- Sweden
- Netherlands
- Turkey
- Switzerland
- Belgium
- Rest of Europe
Asia-Pacific
- South Korea
- Japan
- China
- India
- Australia
- Philippines
- Singapore
- Malaysia
- Thailand
- Indonesia
- Rest of APAC
Latin America
- Mexico
- Colombia
- Brazil
- Argentina
- Peru
- Rest of South America
Middle East and Africa
- Saudi Arabia
- UAE
- Egypt
- South Africa
- Rest of MEA
Key Players
Key Players
- Novo Nordisk A/S (Denmark)
- Bachem Holding AG (Switzerland)
- AstraZeneca (UK)
- Merck KGaA (Germany)
- Amgen Inc. (U.S.)
- Lundbeck A/S (Denmark)
- PeptiDream Inc. (Japan)
- PolyPeptide Group (France)
- Thermo Fisher Scientific Inc. (U.S.)
- AmbioPharm, Inc. (U.S.)
- CordenPharma International GmbH (Germany)
- Lonza Group Ltd. (Switzerland)
- CSBio Company, Inc. (U.S.)
- ChemPartner Co., Ltd. (China)
- Reddy's Laboratories Ltd. (India)
- Teva Pharmaceutical Industries Ltd. (Israel)
- Ferring Pharmaceuticals (Switzerland)
- Pfizer Inc. (U.S.)
